# Ablation of Hepatocellular Carcinoma: a Nationwide Study

> **NCT05498779** · — · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 490 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Ablation
- Hepatitis C

## Interventions

- **PROCEDURE:** Ablation therapy

## Key facts

- **NCT ID:** NCT05498779
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2023-09-01
- **Final completion:** 2023-09-01
- **Target enrollment:** 490 (ACTUAL)
- **Last updated:** 2023-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05498779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05498779, "Ablation of Hepatocellular Carcinoma: a Nationwide Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05498779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*